More than 100 operators from 50 countries have teamed up to develop a unique algorithm for crossing chronic total occlusion (CTO) lesions, with the aim of standardizing techniques and helping ...

Please provide your email address to receive an email when new articles are posted on . Edwards LifeSciences announced the FDA has granted de novo clearance of its hypotension prediction software for ...